
VoxSig. 8AnalysisHealthScience
Scientists are finally starting to figure out Alzheimer’s
The article excerpts a Vox podcast discussion about recent progress in Alzheimer’s research, including FDA-approved amyloid-targeting drugs lecanemab and donanemab, promising tau and inflammation research, and possible GLP-1 benefits. It presents the field as increasingly optimistic after decades of slow progress.










